These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11679997)

  • 1. The protein metabolite theory as a mechanism for the progression of renal failure.
    Niwa T
    J Ren Nutr; 2001 Oct; 11(4):181-2. PubMed ID: 11679997
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
    Tsubakihara Y; Takabatake Y; Oka K; Shoji T; Togawa M; Okada N; Takahito I; Imai E
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of oral-adsorbent (AST-120) in chronic renal failure (CRF) in rats].
    Sakai T; Kumano K; Takara S; Kuwao S; Ise M; Sugano M; Uehara Y
    Nihon Jinzo Gakkai Shi; 1989 Apr; 31(4):359-65. PubMed ID: 2747009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral sorbent AST-120 increases renal NO synthesis in uremic rats.
    Tumur Z; Niwa T
    J Ren Nutr; 2008 Jan; 18(1):60-4. PubMed ID: 18089446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma renin-angiotensin system or protein intake.
    Horike K; Usami T; Kamiya Y; Kamiya T; Yoshida A; Itoh S; Yamato H; Ise M; Kimura G
    Clin Exp Nephrol; 2003 Jun; 7(2):120-4. PubMed ID: 14586730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protein restriction in chronic kidney insufficiency].
    Fliser D; Nowack R; Ritz E
    Urologe A; 1991 Sep; 30(5):W33-40. PubMed ID: 1949432
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics and tissue distribution of uraemic indoxyl sulphate in rats.
    Deguchi T; Nakamura M; Tsutsumi Y; Suenaga A; Otagiri M
    Biopharm Drug Dispos; 2003 Nov; 24(8):345-55. PubMed ID: 14595703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic acidosis and uremic toxicity: protein and amino acid metabolism.
    Price SR; Mitch WE
    Semin Nephrol; 1994 May; 14(3):232-7. PubMed ID: 8036357
    [No Abstract]   [Full Text] [Related]  

  • 9. Protein and energy intake in advanced chronic kidney disease: how much is too much?
    Ikizler TA
    Semin Dial; 2007; 20(1):5-11. PubMed ID: 17244111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amino acid metabolic disorder in kidney failure (a review of the literature)].
    Terekhov NT; Levchenko IV; Lipkan GN
    Vrach Delo; 1982 Nov; (11):12-6. PubMed ID: 6818768
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis.
    Aoyama I; Enomoto A; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S8-14. PubMed ID: 12612943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An oral adsorbent, AST-120, combined with a low-protein diet and RAS blocker, for chronic kidney disease.
    Yorioka N; Kiribayashi K; Naito T; Ogata S; Yokoyama Y; Kyuden Y; Ogawa T; Wada K; Hayashi K; Hirabayashi A
    J Nephrol; 2008; 21(2):213-20. PubMed ID: 18446716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nitrogen metabolism and chronic renal insufficiency].
    Richet G; Meyerovitch A
    Bull Mem Soc Med Hop Paris; 1968; 119(12):977-80. PubMed ID: 5719333
    [No Abstract]   [Full Text] [Related]  

  • 14. Protein nutrition in uremia: a review.
    Kopple JD; Shinaberger JH; Coburn JW; Rubini ME
    Am J Clin Nutr; 1968 May; 21(5):508-15. PubMed ID: 4870146
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of oral adsorbent on experimental uremic rats.
    Kanai F; Takahama T; Yamazaki Z; Idezuki Y; Koide K
    Nihon Jinzo Gakkai Shi; 1986 Sep; 28(9):1249-59. PubMed ID: 3820836
    [No Abstract]   [Full Text] [Related]  

  • 16. Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet.
    Imai E; Takenaka M; Isaka Y; Moriyama T; Akagi Y; Kakuchi J; Fujii T; Ito T; Hori M; Horio M; Syoji T; Tsubakihara Y
    Clin Exp Nephrol; 2003 Jun; 7(2):113-9. PubMed ID: 14586729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone action in chronic kidney disease.
    Amato AA; Santos GM; Neves Fde A
    Curr Opin Endocrinol Diabetes Obes; 2008 Oct; 15(5):459-65. PubMed ID: 18769220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of organic anion transporters in the progression of chronic renal failure.
    Enomoto A; Niwa T
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S27-31. PubMed ID: 17976081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical analysis of renoprotective responding patients administrated with oral adsorbent in chronic renal failure secondary to chronic glomerulonephritis.
    Sanaka T; Akizawa T; Koide K; Koshikawa S
    Ther Apher Dial; 2003 Apr; 7(2):269-78. PubMed ID: 12918955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of PTH, phosphate, and metabolic acidosis on the progression of renal insufficiency in the azotemic rat].
    Jara A; Chacón C; Valdivieso A; Ibaceta M
    Nefrologia; 2003; 23 Suppl 2():37-42. PubMed ID: 12778852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.